BIOMARIN PHARMACEUTICAL INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Novato, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BIOMARIN PHARMACEUTICAL INC has filed 2,724 SEC EDGAR filings since 04 May 1999

SEC filing history

Showing 26-50 of 1,000 matching filings.

Per page
25
Current page
2
4

FORM 4

Filing date
19 Mar 2026
Reporting date
17 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2026
Reporting date
16 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Mar 2026
Reporting date
16 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2026
Reporting date
13 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2026
Reporting date
16 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2026
Reporting date
13 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2026
Reporting date
13 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Mar 2026
Reporting date
11 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
11 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Feb 2026
Reporting date
26 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Feb 2026
Reporting date
25 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
26 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26727

144 filing

Filing date
26 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
13 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
13 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
13 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
13 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
13 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
13 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .